Bio-Techne (TECH)

Nasdaq Health Care Life Sciences Tools & Services S&P 500

$72.78

+0.12 (+0.17%)

Close of Nov 06, 2026 · end-of-day data

Source: Bio-Techne's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$563.00M	$642.99M	$714.01M	$738.69M	$931.03M	$1.11B	$1.14B	$1.16B	$1.22B	$1.22B
Cost of revenue	$188.46M	$210.85M	$240.51M	$255.50M	$298.18M	$349.10M	$366.89M	$389.33M	$429.36M	$415.97M
Gross profit	$374.54M	$432.14M	$473.49M	$483.19M	$632.85M	$756.50M	$769.82M	$769.73M	$790.27M	$799.07M
Research & development	$53.51M	$55.33M	$62.41M	$65.19M	$70.60M	$87.14M	$92.49M	$96.66M	$99.50M	$94.77M
Selling, general & admin	$200.44M	$240.64M	$264.36M	$260.58M	$324.95M	$372.77M	$378.38M	$466.38M	$588.52M	$452.42M
Operating income	$120.58M	$136.18M	$146.72M	$157.42M	$237.30M	$296.59M	$298.94M	$206.69M	$102.25M	$251.89M
Interest expense	$7.36M	$10.19M	$21.70M	$19.20M	$13.95M	$11.31M	$11.21M	$15.74M	$8.51M	$9.63M
Pre-tax income	$111.96M	$125.95M	$112.02M	$276.48M	$148.18M	$301.39M	$338.66M	$185.69M	$98.46M	$240.68M
Income tax	$35.88M	-$198.00K	$15.94M	$47.18M	$8.59M	$38.29M	$53.22M	$17.58M	$25.06M	$58.82M
Net income	$76.09M	$126.15M	$96.07M	$229.30M	$140.41M	$272.05M	$285.26M	$168.10M	$73.40M	$181.84M
EBITDA	$180.62M	$200.64M	$224.89M	$240.16M	$325.04M	$397.66M	$406.18M	$318.40M	$212.16M	$349.25M
EPS (basic)	$2.04	$3.36	$2.54	$6.00	$0.91	$1.73	$1.81	$1.07	$0.47	$1.17
EPS (diluted)	$2.03	$3.31	$2.47	$5.82	$0.87	$1.66	$1.76	$1.05	$0.46	$1.16
Diluted shares	37.50M	38.05M	38.89M	39.40M	161.93M	164.11M	161.85M	160.77M	159.72M	157.01M
Gross margin	66.5%	67.2%	66.3%	65.4%	68.0%	68.4%	67.7%	66.4%	64.8%	65.8%
Operating margin	21.4%	21.2%	20.5%	21.3%	25.5%	26.8%	26.3%	17.8%	8.4%	20.7%
Net margin	13.5%	19.6%	13.5%	31.0%	15.1%	24.6%	25.1%	14.5%	6.0%	15.0%

Balance sheet

fiscal years · USD

Fiscal year	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash & equivalents	$91.61M	$121.99M	$100.89M	$146.62M	$199.09M	$172.57M	$180.57M	$151.79M	$162.19M	$264.71M
Short-term investments	—	—	—	—	$32.46M	$74.46M	$23.74M	$1.07M	—	—
Receivables	$116.83M	$120.30M	$137.47M	$122.53M	$145.38M	$194.55M	$218.47M	$241.39M	$206.88M	$216.59M
Inventory	$85.65M	$85.65M	$91.05M	$103.15M	$116.75M	$141.12M	$171.64M	$179.73M	$189.45M	$195.74M
Total current assets	$348.02M	$398.37M	$412.61M	$520.92M	$510.61M	$605.56M	$621.48M	$617.42M	$608.30M	$744.40M
Goodwill	$579.03M	$597.89M	$732.67M	$728.31M	$843.07M	$822.10M	$872.74M	$972.66M	$980.93M	$975.36M
Total assets	$1.56B	$1.59B	$1.88B	$2.03B	$2.26B	$2.29B	$2.64B	$2.70B	$2.56B	$2.59B
Total current liabilities	$135.52M	$79.51M	$101.98M	$106.67M	$152.28M	$176.02M	$128.51M	$159.38M	$175.85M	$163.70M
Short-term debt	—	—	$12.50M	$12.50M	$12.50M	$12.50M	—	—	—	—
Long-term debt	$343.77M	$339.00M	$492.66M	$344.24M	$328.83M	$243.41M	$350.00M	$319.00M	$346.00M	$200.00M
Total debt	$343.77M	$339.00M	$505.16M	$356.74M	$341.33M	$255.91M	$350.00M	$319.00M	$346.00M	$200.00M
Total liabilities	$608.59M	$514.14M	$718.82M	$646.40M	$699.99M	$593.03M	$672.18M	$635.02M	$639.06M	$478.50M
Shareholders' equity	$949.63M	$1.08B	$1.17B	$1.38B	$1.56B	$1.70B	$1.97B	$2.07B	$1.92B	$2.11B

Cash flow

fiscal years · USD

Fiscal year	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Operating cash flow	$143.72M	$170.37M	$181.62M	$205.22M	$352.16M	$325.27M	$254.39M	$298.98M	$287.56M	$292.07M
Capital expenditures	$15.18M	$20.93M	$25.41M	$51.74M	$44.30M	$44.91M	$38.24M	$62.88M	$31.01M	$28.85M
Free cash flow	$128.54M	$149.43M	$156.21M	$153.47M	$307.86M	$280.36M	$216.15M	$236.10M	$256.55M	$263.22M
Investing cash flow	-$305.95M	-$38.71M	-$336.80M	$27.09M	-$243.52M	-$96.85M	-$265.65M	-$203.03M	-$35.18M	-$18.19M
Financing cash flow	$189.11M	-$99.19M	$134.38M	-$183.80M	-$62.55M	-$242.85M	$22.62M	-$122.40M	-$253.91M	-$169.11M
Dividends paid	$47.33M	$47.97M	$48.36M	$48.90M	$49.62M	$50.19M	$50.28M	$50.42M	$50.39M	$49.92M
Share buybacks	—	$0	$15.40M	$50.11M	$43.18M	$160.95M	$19.56M	$80.04M	$275.73M	$41.67M
Stock-based compensation	$14.63M	$28.24M	$32.28M	$32.37M	$48.98M	$42.18M	$39.23M	$38.04M	$40.83M	$41.37M
Depreciation & amortization	$60.04M	$64.46M	$78.17M	$82.74M	$87.75M	$101.07M	$107.24M	$111.71M	$109.90M	$97.36M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$272.60M	$303.43M	$306.10M	$289.46M	$297.03M	$316.18M	$316.96M	$286.56M	$295.88M	$311.42M	$321.19M	$299.71M
Cost of revenue	$96.01M	$98.83M	$102.75M	$106.44M	$103.14M	$101.62M	$118.15M	$98.44M	$104.60M	$103.13M	$109.80M	$103.09M
Gross profit	$176.59M	$204.60M	$203.35M	$183.02M	$193.89M	$214.56M	$198.81M	$188.11M	$191.28M	$208.29M	$211.39M	$196.62M
Research & development	$22.92M	$25.76M	$23.99M	$23.87M	$25.02M	$24.58M	$26.03M	$24.24M	$23.12M	$23.45M	$23.95M	$26.34M
Selling, general & admin	$115.67M	$111.84M	$133.54M	$119.16M	$121.45M	$151.27M	$196.64M	$116.21M	$113.69M	$109.34M	$113.17M	$133.68M
Operating income	$38.00M	$67.00M	$45.82M	$39.99M	$47.42M	$38.71M	-$23.86M	$47.66M	$54.46M	$75.50M	$74.28M	$36.60M
Interest expense	$4.33M	$4.00M	$2.51M	$2.18M	$2.15M	$2.01M	$2.18M	$2.93M	$2.17M	$2.40M	$2.12M	$2.17M
Pre-tax income	$33.39M	$61.08M	$41.66M	$40.17M	$42.88M	$38.27M	-$22.86M	$47.99M	$50.78M	$71.22M	$70.68M	$34.69M
Income tax	$5.92M	$12.03M	$1.07M	$6.57M	$7.99M	$15.69M	-$5.18M	$9.81M	$12.78M	$20.18M	$16.06M	$6.40M
Net income	$27.46M	$49.06M	$40.59M	$33.60M	$34.89M	$22.59M	-$17.68M	$38.19M	$38.01M	$51.05M	$54.64M	$28.29M
EBITDA	$65.81M	$94.31M	$73.88M	$68.12M	$74.50M	$66.28M	$3.25M	$72.00M	$79.17M	$99.66M	$98.42M	$60.33M
EPS (basic)	$0.17	$0.31	$0.26	$0.21	$0.22	$0.14	$-0.11	$0.25	$0.24	$0.33	$0.35	$0.18
EPS (diluted)	$0.17	$0.31	$0.26	$0.21	$0.22	$0.14	$-0.11	$0.24	$0.24	$0.32	$0.35	$0.18
Diluted shares	160.06M	160.50M	-43.00K	161.12M	160.63M	158.94M	-945.00K	156.36M	157.00M	157.40M	66.00K	157.93M
Gross margin	64.8%	67.4%	66.4%	63.2%	65.3%	67.9%	62.7%	65.6%	64.6%	66.9%	65.8%	65.6%
Operating margin	13.9%	22.1%	15.0%	13.8%	16.0%	12.2%	-7.5%	16.6%	18.4%	24.2%	23.1%	12.2%
Net margin	10.1%	16.2%	13.3%	11.6%	11.7%	7.1%	-5.6%	13.3%	12.8%	16.4%	17.0%	9.4%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$130.13M	$139.91M	$151.79M	$187.54M	$177.55M	$140.67M	$162.19M	$144.96M	$172.88M	$209.82M	$264.71M	$350.04M
Short-term investments	$5.52M	$5.40M	$1.07M	—	$0	$0	—	—	—	—	—	—
Receivables	$207.45M	$227.89M	$241.39M	$223.69M	$217.94M	$237.14M	$206.88M	$183.90M	$184.61M	$214.56M	$216.59M	$203.06M
Inventory	$180.84M	$179.50M	$179.73M	$185.04M	$188.37M	$191.08M	$189.45M	$203.19M	$205.45M	$201.18M	$195.74M	$197.67M
Total current assets	$590.64M	$610.65M	$617.42M	$648.57M	$634.64M	$627.24M	$608.30M	$609.51M	$637.43M	$688.05M	$744.40M	$824.83M
Goodwill	$980.08M	$970.97M	$972.66M	$982.59M	$964.61M	$968.61M	$980.93M	$978.91M	$980.56M	$977.80M	$975.36M	$972.07M
Total assets	$2.73B	$2.72B	$2.70B	$2.74B	$2.67B	$2.64B	$2.56B	$2.53B	$2.52B	$2.55B	$2.59B	$2.64B
Total current liabilities	$135.23M	$149.82M	$159.38M	$142.13M	$161.26M	$169.20M	$175.85M	$144.54M	$140.43M	$153.28M	$163.70M	$361.27M
Short-term debt	—	—	—	—	—	—	—	—	—	—	—	$200.00M
Long-term debt	$447.00M	$389.00M	$319.00M	$300.00M	$300.00M	$330.00M	$346.00M	$300.00M	$260.00M	$200.00M	$200.00M	—
Total debt	$447.00M	$389.00M	$319.00M	$300.00M	$300.00M	$330.00M	$346.00M	$300.00M	$260.00M	$200.00M	$200.00M	$200.00M
Total liabilities	$767.19M	$706.79M	$635.02M	$597.37M	$591.93M	$626.23M	$639.06M	$560.33M	$511.71M	$465.30M	$478.50M	$471.13M
Shareholders' equity	$1.96B	$2.01B	$2.07B	$2.14B	$2.08B	$2.02B	$1.92B	$1.97B	$2.01B	$2.09B	$2.11B	$2.17B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$83.12M	$80.99M	$75.50M	$63.89M	$84.35M	$41.12M	$98.20M	$27.59M	$82.41M	$86.66M	$95.42M	$73.11M
Capital expenditures	$14.86M	$16.44M	$17.98M	$9.17M	$6.82M	$10.12M	$4.89M	$5.36M	$5.92M	$9.09M	$8.48M	$5.92M
Free cash flow	$68.25M	$64.55M	$57.52M	$54.72M	$77.53M	$31.00M	$93.31M	$22.22M	$76.49M	$77.58M	$86.94M	$67.20M
Investing cash flow	-$23.67M	-$16.44M	-$8.81M	-$21.68M	-$5.03M	-$8.87M	$406.00K	$605.00K	-$5.92M	-$5.82M	-$7.06M	-$3.93M
Financing cash flow	-$81.40M	-$52.42M	-$60.09M	-$11.57M	-$83.84M	-$68.05M	-$90.45M	-$44.20M	-$48.99M	-$42.72M	-$33.21M	$16.39M
Dividends paid	$12.56M	$12.58M	$12.63M	$12.69M	$12.74M	$12.58M	$12.39M	$12.44M	$12.47M	$12.52M	$12.48M	$12.56M
Share buybacks	—	$0	$0	—	—	$100.05M	$100.06M	$24.00K	$0	$0	$41.65M	—
Stock-based compensation	$12.75M	$8.13M	$7.06M	$10.18M	$14.71M	$11.39M	$4.55M	$11.68M	$13.96M	$10.49M	$5.23M	$13.41M
Depreciation & amortization	$27.80M	$27.31M	$28.06M	$28.14M	$27.08M	$27.57M	$27.11M	$24.34M	$24.71M	$24.17M	$24.14M	$23.73M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.